Applicant, as named in the Orange Book
Oyster Point Pharma
Next listed expiry: Tyrvaya on 19 Oct 2035. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Tyrvaya NDA 213978 varenicline tartrate | 19 Oct 2035 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.